Evidence map›Paper›PMID 16107870›Full record

ArticleGenes and immunity2005

Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis.

M F Seldin, R Shigeta, K Laiho, H Li, H Saila, A Savolainen, M Leirisalo-Repo, K Aho, E Tuomilehto-Wolf, K Kaarela and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 5 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 5 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The association between the functional PTPN22 1858 C/T and MIF -173 C/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2012
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Genetic association between theExperimental and therapeutic medicine · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

M F SeldinRowe Program in Genetics, Departments of Biochemistry and Medicine, University of California-Davis, Davis, CA, USA. mdfseldin@ucdavis.edu
R Shigeta
K Laiho
H Li
H Saila
A Savolainen
M Leirisalo-Repo
K Aho
E Tuomilehto-Wolf
K Kaarela
M Kauppi
H C Alexander
A B Begovich
J Tuomilehto
University of California, Davis · USHelsinki University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies have identified the PTPN22 allelic variant 1858 C/T that encodes the R620W amino-acid change as a putative susceptibility factor in autoimmune diseases. The current study was undertaken to examine a large cohort of Finnish rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) subjects using both population control and, importantly, family-based association methods. The latter is particularly important when, as is the case for the 1858 C/T polymorphism, the frequency of the variant allele (T) differs in both major ancestral populations and in subpopulations. The analysis of rheumatoid factor-positive 1030 RA probands from Finland provides strong support for association of this variant in both population studies (allele specific odds ratio (OR)=1.47, 95% confidence interval (CI)=1.27-1.70, P=3 x 10(-7)) and in family studies (P<10(-6)). In contrast, no allelic association was seen with JIA (230 probands) and only weak evidence for a genotypic effect of 1858T homozygotes was observed in this population.

Indexed as

Polymorphism, GeneticRisk FactorsAllelesArthritis, JuvenileArthritis, RheumatoidCase-Control StudiesCohort StudiesConfidence IntervalsFinlandGene FrequencyGenetics, PopulationGenetic VariationNuclear FamilyOdds RatioProtein Tyrosine Phosphatase, Non-Receptor Type 22Protein Tyrosine PhosphatasesProtein Tyrosine Phosphatase, Non-Receptor Type 22Protein Tyrosine Phosphatases

Identifiers

PMID16107870
OpenAlexW2072374968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.